METASTATIC BLADDER CARCINOMA
Clinical trials for METASTATIC BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Cancer's weak spot: a hopeful trial for Tough-to-Treat tumors
Disease control Recruiting nowThis study is testing whether a pill called olaparib can help control advanced bladder and other urinary cancers that have specific DNA repair defects and have stopped responding to standard treatments like chemotherapy. The drug works by blocking a protein that helps cancer cell…
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for rare cancers: Triple-Threat therapy trial opens
Disease control Recruiting nowThis study is testing a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—for patients with rare types of bladder, kidney, penile, and other urinary tract cancers that have spread. The goal is to see if this three-drug approach can shrink tumors and control the d…
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New support program aims to help bladder cancer patients navigate complex treatment
Symptom relief Recruiting nowThis study is testing an education and navigation support tool designed to help patients with advanced bladder cancer and their caregivers participate more actively in treatment decisions and care planning. The program provides educational resources, connects patients to support …
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Feb 17, 2026 14:36 UTC